<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

43

No.

24

June 16, 2017Jun 16, 2017

DOWNLOAD THE PDF

Ned Sharpless, Trump's choice for NCI director, described as erudite scientist whose expertise spans basic, clinical research

Cover Story

Ned Sharpless, Trump's choice for NCI director, described as erudite scientist whose expertise spans basic, clinical research

By Paul Goldberg

President Donald Trump announced his intention to name Norman “Ned” Sharpless to serve as the next NCI director. The appointment was announced late on June 9.

Sandoz prevails over Amgen in Supreme Court case on marketing biosimilars

Sandoz prevails over Amgen in Supreme Court case on marketing biosimilars

By Claire Dietz

NIH plans to set aside up to $1.1 billion a year to fund more young investigators

NIH plans to set aside up to $1.1 billion a year to fund more young investigators

By Matthew Bin Han Ong

Recent Issues

Volume 51 | Issue 40 - October 31, 2025

Volume 51 | Issue 39 - October 24, 2025

Volume 51 | Issue 38 - October 17, 2025

Volume 51 | Issue 37 - October 10, 2025

Volume 51 | Issue 36 - October 03, 2025

Volume 51 | Issue 35 - September 26, 2025